Abstract: Objective: To analyze the incidence and mortality of liver cancer in Beijing from 2013 to 2017, to provide scientific strategy for liver cancer prevention and treatment.
Method: The data from Beijing cancer registry during 2003—2017 were collected and qualified to calculate the crude incidence and mortality rate, age-standardized rate, cumulative rate (0-74 years) and annual percentage change (APC).
Result: There were 37 459 cases diagnosed as liver cancer during 2003—2017 with a crude incidence rate of 19.92/105. The age-standardized incidence rate by Chinese standard population (ASR China) in 2000 and world standard population (ASR World) of liver cancer were 11.42/105 and 11.29/105, respectively. The male to female incidence ratio of ASR world was 3.07:1. The incidence in urban areas was lower than that in rural area with a ratio of 0.79:1. The cases of liver cancer deaths were about 30 945, with a crude mortality rate of 16.46/105. The ASR China and ASR World mortality rate were 9.15/105 and 9.04/105. The male to female mortality ratio of ASR world was 3.09:1. The mortality in urban areas was lower than that in rural area with a ratio of 0.77:1. The APC of ASR World for incidence of liver cancer was -2.33% (95%CI: -3.3%--1.3%, P<0.001), the APC of ASR World for mortality of liver cancer was -1.53% (95%CI: -2.5%--0.5%, P=0.005). The incidence rate and the mortality rate peaked in the age group of 80-84 years and 85+ years, respectively.
Conclusion: The incidence and mortality rates of liver cancer in Beijing were decreasing in the past 15 years, the rates were still higher than the average level of world. The disease burden can not be ignored. The incidence and mortality rates of liver cancer in Beijing were higher for male than those in female, and higher in rural area than that in urban area, suggesting the prevention and treatment of liver cancer should continue to be strengthened in the middle-aged and elderly men and rural people.

Key words: Liver cancer, Incidence, Mortality, Beijing